Isturisa for Cushing's disease
Quick answer: Isturisa is used for Cushing's disease as part of a 11-beta-hydroxylase inhibitor treatment regimen. Inhibits 11-beta-hydroxylase (CYP11B1), blocking cortisol synthesis in the adrenal cortex The specific dosing for Cushing's disease is determined by your prescriber based on individual factors.
Why is Isturisa used for Cushing's disease?
Isturisa belongs to the 11-beta-hydroxylase inhibitor class. Inhibits 11-beta-hydroxylase (CYP11B1), blocking cortisol synthesis in the adrenal cortex This action makes it useful for treating or managing Cushing's disease in patients for whom this approach is clinically appropriate.
It is one of several treatment options. Whether Isturisa is the right choice for a specific patient depends on the type and severity of Cushing's disease, response to previous treatments, individual risk factors, and clinical guidelines.
Typical dosing for Cushing's disease
Common adult dosing range: 2 mg twice daily, titrated up to 30 mg twice daily. The actual dose for Cushing's disease depends on:
- Severity of the condition
- Patient's age, weight, and organ function
- Other medications being taken
- Treatment response and tolerability
For complete dosing details, see the Isturisa medicine page.
What to expect
Isturisa treatment for Cushing's disease typically involves:
- Onset of effect: varies by indication and dose — some effects are immediate, others take days to weeks
- Treatment duration: some courses are short-term, others are long-term or lifelong depending on Cushing's disease
- Monitoring: follow-up visits to assess response and adjust dosing
- Side-effect awareness: learning what to expect and what warrants medical attention
Alternatives to consider
If Isturisa is not appropriate or not tolerated, alternatives within the same class or different therapeutic classes may be considered. See all 11-beta-hydroxylase inhibitor for related options.
When to talk to your doctor
Discuss with your prescriber if you experience:
- Inadequate symptom control on Isturisa
- Side effects affecting daily life
- New medications or supplements that may interact
- Pregnancy planning or pregnancy
- Major changes in health status
Related information
Isturisa full prescribing information · All 11-beta-hydroxylase inhibitor alternatives
Frequently asked questions
How effective is Isturisa for Cushing's disease?
Effectiveness varies by individual response, dose, and severity. Isturisa is one of several treatment options for Cushing's disease, supported by clinical evidence within the 11-beta-hydroxylase inhibitor class. Discuss expected response with your prescriber.
How long do I need to take Isturisa for Cushing's disease?
Treatment duration depends on the nature of Cushing's disease — some treatments are short-term, others long-term or lifelong. Never stop on your own; discontinuation requires clinical guidance to avoid relapse or rebound effects.
What are the main side effects of Isturisa when used for Cushing's disease?
Common and serious side effects are class-related and substance-specific. See the full medicine page for the complete profile. Report any unexpected effects to your prescriber.
Are there alternatives to Isturisa for Cushing's disease?
Yes. Multiple medicines and non-drug options exist for Cushing's disease. Alternatives within the 11-beta-hydroxylase inhibitor class share mechanisms; other classes may offer different approaches. Discuss with your clinician.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.